The Metformin for Abdominal Aortic Aneurysm Growth Inhibition (MAAAGI) trial has been testing whether the world’s most common antidiabetic drug, metformin, can stop aneurysm growth or even ...

Of the 1,200 patients, 531 (44.3%) underwent endovascular aneurysm repair (EVAR). The average age was 74 years, and 13% were female. Aortouni-iliac grafts were used in 49.4% of patients ...